Privium Fund Management B.V. — 13F Holdings & Portfolio
CIK 1795097 · latest 13F-HR filed 2026-08-07
Privium Fund Management B.V. manages $544.2M in 13F-reported U.S. long-equity assets across 61 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are TSLA (17.62%), SHOP (7.76%), AMD (6.62%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 12 new positions, exited 11, added to 29, and trimmed 16.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
AMSTERDAM, P7 1082 MS
$544.2M
Long-equity book
61
Distinct positions
2026-06-30
Filed 2026-08-07
+12 / −11 / ↑29 / ↓16
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ADVANCED MICRO DEVICES INC$23.4M +185.6%
- TESLA INC$13.4M +16.2%
- AMAZON COM INC$7.3M +28.2%
- UNIQURE NV$7.2M +90.1%
- IREN LIMITED$4.6M +41.7%
Top Trims
- SPOTIFY TECHNOLOGY S A-$7.2M -22.3%
- SHOPIFY INC-$6.0M -12.5%
- PALANTIR TECHNOLOGIES INC-$5.9M -20.2%
- ARROWHEAD PHARMACEUTICALS IN-$3.9M -17.0%
- BIOMARIN PHARMACEUTICAL INC-$922.8K -17.7%
New Positions
- OPENDOOR TECHNOLOGIES INC$18.2M
- CEREBRAS SYSTEMS INC$13.4M
- SPACE EXPLORATION TECHN CORP$6.8M
- MAGNUM ICE CREAM CO NV$1.5M
- ZOETIS INC$1.2M
Exited Positions
- COINBASE GLOBAL INC$13.8M
- SEA LTD$11.4M
- ESPERION THERAPEUTICS INC NE$9.0M
- ENGENE HOLDINGS INC$2.4M
- STOKE THERAPEUTICS INC$1.6M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | TESLA INC | TSLA | 88160R101 | $95.9M | 17.62% | 228,000 | SH |
| 2 | SHOPIFY INC | SHOP | 82509L107 | $42.2M | 7.76% | 370,000 | SH |
| 3 | ADVANCED MICRO DEVICES INC | AMD | 007903107 | $36.0M | 6.62% | 62,000 | SH |
| 4 | AMAZON COM INC | AMZN | 023135106 | $33.4M | 6.13% | 140,000 | SH |
| 5 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $25.4M | 4.66% | 319,924 | SH |
| 6 | SPOTIFY TECHNOLOGY S A | SPOT | L8681T102 | $25.3M | 4.64% | 55,000 | SH |
| 7 | PALANTIR TECHNOLOGIES INC | PLTR | 69608A108 | $23.3M | 4.29% | 200,000 | SH |
| 8 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 04280A100 | $19.1M | 3.51% | 234,222 | SH |
| 9 | OPENDOOR TECHNOLOGIES INC | OPEN | 683712103 | $18.2M | 3.35% | 3,940,904 | SH |
| 10 | LEMONADE INC | LMND | 52567D107 | $17.6M | 3.23% | 270,259 | SH |
| 11 | NVIDIA CORPORATION | NVDA | 67066G104 | $16.2M | 2.98% | 81,000 | SH |
| 12 | IREN LIMITED | IREN | Q4982L109 | $15.6M | 2.86% | 340,150 | SH |
| 13 | UNIQURE NV | QURE | N90064101 | $15.1M | 2.78% | 328,322 | SH |
| 14 | CEREBRAS SYSTEMS INC | CBRS | 15675D103 | $13.4M | 2.46% | 60,500 | SH |
| 15 | AST SPACEMOBILE INC | ASTS | 00217D100 | $12.9M | 2.37% | 145,000 | SH |
| 16 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 90400D108 | $11.3M | 2.08% | 338,800 | SH |
| 17 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 03969K108 | $10.5M | 1.92% | 399,367 | SH |
| 18 | BIOGEN INC | BIIB | 09062X103 | $10.5M | 1.92% | 48,400 | SH |
| 19 | PROQR THRAPEUTICS N V | PRQR | N71542109 | $10.3M | 1.89% | 5,520,024 | SH |
| 20 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $9.8M | 1.80% | 39,944 | SH |
| 21 | UROGEN PHARMA LTD | URGN | M96088105 | $7.7M | 1.42% | 210,000 | SH |
| 22 | SPACE EXPLORATION TECHN CORP | SPCX | 84615Q103 | $6.8M | 1.26% | 40,000 | SH |
| 23 | DENALI THERAPEUTICS INC | DNLI | 24823R105 | $5.9M | 1.09% | 229,857 | SH |
| 24 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $4.7M | 0.86% | 9,400 | SH |
| 25 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $4.3M | 0.79% | 75,000 | SH |
| 26 | KRYSTAL BIOTECH INC | KRYS | 501147102 | $4.2M | 0.76% | 11,170 | SH |
| 27 | ALNYLAM PHARMACEUTICALS INC | ALNY | 02043Q107 | $3.4M | 0.63% | 11,372 | SH |
| 28 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $3.2M | 0.59% | 173,516 | SH |
| 29 | BIONTECH SE | BNTX | 09075V102 | $2.8M | 0.51% | 30,100 | SH |
| 30 | HIMS & HERS HEALTH INC | HIMS | 433000106 | $2.8M | 0.51% | 80,000 | SH |
| 31 | MEIRAGTX HLDGS PLC | MGTX | G59665102 | $2.6M | 0.49% | 196,112 | SH |
| 32 | AMBEV SA | ABEV | 02319V103 | $2.5M | 0.46% | 802,167 | SH |
| 33 | SAREPTA THERAPEUTICS INC | SRPT | 803607100 | $2.5M | 0.45% | 136,500 | SH |
| 34 | CRISPR THERAPEUTICS AG | CRSP | H17182108 | $2.5M | 0.45% | 44,974 | SH |
| 35 | BEAM THERAPEUTICS INC | BEAM | 07373V105 | $2.4M | 0.44% | 70,282 | SH |
| 36 | ZAI LAB LTD | ZLAB | 98887Q104 | $2.3M | 0.43% | 122,189 | SH |
| 37 | MODERNA INC | MRNA | 60770K107 | $2.1M | 0.39% | 29,994 | SH |
| 38 | CARTESIAN THERAPEUTICS INC | RNAC | 816212302 | $1.6M | 0.29% | 151,675 | SH |
| 39 | MAGNUM ICE CREAM CO NV | MICC | N5505D105 | $1.5M | 0.27% | 98,221 | SH |
| 40 | WAVE LIFE SCIENCES LTD | WVE | Y95308105 | $1.4M | 0.26% | 241,010 | SH |
| 41 | TAYSHA GENE THERAPIES INC | TSHA | 877619106 | $1.4M | 0.25% | 198,900 | SH |
| 42 | ZOETIS INC | ZTS | 98978V103 | $1.2M | 0.23% | 17,322 | SH |
| 43 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 35104E100 | $1.2M | 0.22% | 90,110 | SH |
| 44 | FATE THERAPEUTICS INC | FATE | 31189P102 | $1.1M | 0.21% | 414,311 | SH |
| 45 | LEGEND BIOTECH CORP | LEGN | 52490G102 | $1.0M | 0.19% | 35,400 | SH |
| 46 | ROCKET PHARMACEUTICALS INC | RCKT | 77313F106 | $835.0K | 0.15% | 244,146 | SH |
| 47 | NOV INC | NOV | 62955J103 | $779.6K | 0.14% | 42,026 | SH |
| 48 | B2GOLD CORP | BTG | 11777Q209 | $729.6K | 0.13% | 195,083 | SH |
| 49 | TOTALENERGIES SE | TTE | F92124100 | $729.5K | 0.13% | 10,723 | SH |
| 50 | LEXEO THERAPEUTICS INC | LXEO | 52886X107 | $722.3K | 0.13% | 155,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-07 | $544.2M | 61 | 0001754960-26-000698 |
| 2026-03-31 | 2026-05-05 | $480.3M | 60 | 0001754960-26-000356 |
| 2025-12-31 | 2026-02-03 | $543.1M | 57 | 0001754960-26-000150 |